Transcriptional networks that control the development of organisms are precise, highly coordinated, and complex. This proposal seeks to understand how the same transcription factor can specify multiple distinct cell fates during the development of an organism. Specifically, we are interested in the transcription factor Olig2, which can promote both a motoneuron and an oligodendrocyte cell fate. We hypothesize that Olig2 is able to perform its multiple functions through interactions with other DNA binding proteins causing it to bind different targets in different cellular contexts. Testing this hypothesis using current methods for the analysis of transcription factors is difficult because they cannot trace binding throughout a cell lineage, making it impossible to correlate DNA-binding events in progenitor cells to the final cell fates of their progeny. We propose to use a novel method, transposon "Calling Cards", to record Olig2 binding during neural differentiation. The method entails fusing the transposase of a transposon to a transcription factor, thereby causing it to direct the insertion of transposon DNA into the genome near where it binds. The transposon becomes a "Calling Card" that permanently marks the transcription factor's visit to that place in the genome. By recovering these Calling Cards along with some of the genomic DNA that flanks them and then determining their DNA sequences, it is possible to map the genome-wide binding history of the transcription factor. We propose to apply the Calling Card method to understand how Olig2 carries out its distinct functions. Since many important transcription factors perform more than one function during development, the insights that we gain from this work should be broadly applicable.
Our specific aims are 1) to trace Olig2 binding through neural stem cell differentiation to understand how it promotes two distinct cell fates, 2) to confirm that differentially bound target genes promote motoneuron or oligodendrocyte cell fates, 3) to analyze Olig2 and Ngn2 binding in living zebrafish using Calling Card technology.
These aims are feasible: we have successfully implemented the Calling Card method in both yeast and mammalian cells, and our preliminary results demonstrate transcription factor directed insertion of Calling Cards in zebrafish. We are confident that the rewards of further developing this technology and applying it to understand the process of cell fate specification will be substantial

Public Health Relevance

For neurons to properly function, they must be coated with an insulating material called myelin. The cells that produce and maintain myelin are called oligodendrocytes, and if they are damaged or compromised, the nervous system becomes impaired, causing diseases like multiple sclerosis. One possible way to treat diseases caused by myelin loss is to differentiate stems cells to generate oligodendrocytes or their precursors. These cells could then be used to replace the dysfunctional oligodendrocytes. However, we are not yet facile at controlling stem cell differentiation. This proposal seeks to understand the mechanism by which stem cells differentiate into oligodendrocytes using a novel method that will allow us to analyze this process in a way that has not previously been possible. It is our hope that a better understanding of oligodendrocyte differentiation will ultimately translate into stem cell based treatments for demyelinating diseases.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Genomics, Computational Biology and Technology Study Section (GCAT)
Program Officer
Lavaute, Timothy M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Mayhew, David; Mitra, Robi D (2014) Transcription factor regulation and chromosome dynamics during pseudohyphal growth. Mol Biol Cell 25:2669-76
Mitra, Rupak; Li, Xianghong; Kapusta, Aurelie et al. (2013) Functional characterization of piggyBat from the bat Myotis lucifugus unveils an active mammalian DNA transposon. Proc Natl Acad Sci U S A 110:234-9